Literature DB >> 6452523

Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis.

N I Abdou, H B Lindsley, L S Racela, E Pascual, K M Hassanein.   

Abstract

Suppressor T cell hypofunction was found in active early rheumatoid arthritis (RA) (disease less than 3 months) and not in active late RA (greater than 6 months) or inactive RA. Active early RA patients when they were restudied 11-23 months later had normal suppressor cell function despite persistence of disease activity. Anti-suppressor cell antibody of the IgG class could be detected in plasma from active early RA patients and not in plasma from the other RA groups or the non RA controls. B cell targets for the Concanavalin A activated suppressor T cells were found to be functionally normal in early active RA. Suppressor cell hypofunction may contribute to the initiation, but not the persistence of rheumatoid synovitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6452523

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Feedback regulation of antibody production: a role in rheumatoid arthritis?

Authors:  J K Kalsi; N D Hall
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Modulatory effects of fibronectin on in vitro lymphocyte responses.

Authors:  L H Sigal
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

3.  Chronic monoarthritis and foot-drop as a paraneoplastic syndrome in prostate cancer.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2010-07-22       Impact factor: 2.631

4.  In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes.

Authors:  C Plater-Zyberk; M F Clarke; K Lam; P A Mumford; G R Room; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

5.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Impaired release of a T-cell specific suppressor factor in rheumatoid arthritis.

Authors:  C Lau; S Budz-Tymkewycz; M Ramsden; P Lee; E C Keystone
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Spontaneous and aggregated IgG induced rheumatoid factor producing cells in rheumatoid arthritis.

Authors:  E J Pisko; R A Turner; M Panetti; S L Foster; E Heise
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

8.  T cell subsets in patients with rheumatoid arthritis: reduction of cells with Leu 2A phenotype in patients with serum IgG immunocomplexes.

Authors:  M V Queiros; B Rocha
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Origin of defective T lymphocyte-suppressor activating factor interaction in patients with rheumatoid arthritis.

Authors:  E C Keystone; S Budz-Tymkewycz; M Toews; C Lau
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

10.  Possible disease-modifying effects of naproxen in the adjuvant-arthritic rat.

Authors:  N R Ackerman; K Kappas; P Maloney
Journal:  Agents Actions       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.